Recruiting studies: Newly Diagnosed Peripheral T Cell Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL
Phase 3 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05931263 Genotype-guided Treatment in Newly Diagnosed PTCL
Phase 1/Phase 2 · 1 location(s) · Ruijin Hospital · NCT05675813 PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NA · 1 location(s) · Ruijin Hospital · NCT05662540 Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06824883 A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04365036 A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of New
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06630091 Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
Phase 2 · 1 location(s) · Won Seog Kim · NCT05477264 To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Phase 3 · 69 location(s) · Acrotech Biopharma Inc. · NCT06072131 Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Phase 2 · 4 location(s) · St. Jude Children's Research Hospital · NCT06390319 Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phe
Phase 3 · 1 location(s) · Chipscreen Biosciences, Ltd. · NCT06947967 Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Pe
Phase 2 · 1 location(s) · Liling Zhang · NCT05976997 Golidocitinib Plus CHOP in Newly Diagnosed PTCL
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06739265 Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Phase N/A · 6 location(s) · Associazione Angela Serra per la ricerca sul cancro · NCT03964480 Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06583083 Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT05833893

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.